MedRx Co., Ltd (TYO:4586)
50.00
+11.00 (28.21%)
Nov 17, 2026, 3:30 PM JST
MedRx Revenue
MedRx had revenue of 2.00M JPY in the quarter ending September 30, 2026, a decrease of -98.00%. This brings the company's total for the last twelve months to 23.00M, down -80.83% year-over-year. In the year 2025, MedRx had annual revenue of 128.00M, down -50.19%. That makes MedRx the 45,805th largest company in the world by revenue and 3,873rd in Japan.
Revenue (ttm)
23.00M
Revenue Growth
-80.83%
P/S Ratio
152.19
Revenue / Employee
1.10M
Employees
21
Market Cap
3.50B
Revenue by Geography
- Japan 103.98M 81.2%
- United States of America 24.11M 18.8%
Fiscal year ended Dec 31, 2025 See the full MedRx breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 128.00M | -129.00M | -50.19% |
| Dec 31, 2024 | 257.00M | 228.00M | 786.21% |
| Dec 31, 2023 | 29.00M | -30.00M | -50.85% |
| Dec 31, 2022 | 59.00M | 51.00M | 637.50% |
| Dec 31, 2021 | 8.00M | -107.00M | -93.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharma Foods International | 63.22B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Fuji Pharma | 62.39B |
| Daito Pharmaceutical | 49.53B |
| Nippon Chemiphar | 32.98B |
| Koa Shoji Holdings | 24.50B |
| Morishita Jintan | 12.84B |
| Mizuho Medy | 10.82B |